mRNA Vaccines in Infectious Diseases Market Outlook and Trends by Opportunities, Challenges, Unmet Needs, and Competitive Landscape
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
mRNA Vaccines in Infectious Diseases Market Report Overview
The first mRNA vaccines for COVID-19 gained authorization for use in December 2020. These vaccines have been proven highly successful clinically and commercially, dominating the COVID-19 vaccine market. Furthermore, the success of the COVID-19 mRNA vaccines has renewed interest in mRNA vaccines for a variety of other infectious diseases such as influenza, respiratory syncytial virus (RSV), cytomegalovirus (CMV), Mpox, herpes, Zika virus, and Lyme disease. The report provides an assessment of the mRNA vaccines space, including the history of mRNA Therapeutics Development, industry trends, marketed products, pipeline products, opportunities, challenges, and unmet needs, current companies, and a brief market outlook.
Messenger RNA (mRNA) is a single-stranded ribonucleic acid that is transcribed from a strand of DNA. mRNA carries the coding information for protein synthesis. mRNA vaccines use mRNA that corresponds to a viral protein, such as a small piece of protein found on the outer membrane, to induce an immune response. The body produces spike proteins triggered by the mRNA, which look like the antigens of the viral protein.
| Key Marketed Products | · Comirnaty (BNT162b2/tozinameran)
· Spikevax (mRNA-1273) · Nuvaxovid XBB.1.5 · Gemcovac-19 · AWcorna (Walvax) · Daichirona (DS-5670) |
| Key Pipeline Products | · ARCT-2301
· DS-5670b · BNT-162b5 · LVRNA-009 · mRNA-1283 |
| Key Companies | · Moderna
· BioNTech · Pfizer · Arcturus Therapeutics · AIM Vaccine Co Ltd |
| Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
mRNA Vaccines in Infectious Diseases Market by Marketed Products
The rapid sequencing of the SARS-CoV-2 viral genome and the subsequent development of mRNA vaccines in response to the COVID-19 pandemic occurred at unprecedented speed and marked a critical milestone in vaccinology. The mRNA vaccines for COVID-19 are dominating the COVID-19 vaccine market owing to its clinical and commercial success. Revenues for mRNA COVID-19 vaccines peaked in 2022, with Moderna’s Spikevax and Pfizer and BioNTech’s Comirnaty generating around $18.4 billion and $42.4 billion in global revenues in the same year.
The key market products in the mRNA vaccines in the infectious diseases market are Comirnaty (BNT162b2/tozinameran), Spikevax (mRNA-1273), Nuvaxovid XBB.1.5, Gemcovac-19, AWcorna (Walvax), and Daichirona (DS-5670) among others.
Spikevax (mRNA-1273): The product demonstrates the potential of Moderna’s broad mRNA vaccine platform. Furthermore, it offers the potential for booster dose label expansions.
Key Marketed Products for mRNA Vaccines in the Infectious Diseases Market
Buy the Full Report for Additional Insights on the Key Marketed Products for mRNA Vaccines in the Infectious Diseases Market, Download a Free Sample Report
mRNA Vaccines in Infectious Diseases Market by Pipeline Products
The key pipeline products for mRNA vaccines in the infectious diseases market are ARCT-2301, DS-5670b, BNT-162b5, LVRNA-009, and mRNA-1283 among others. These pipeline products are classified based on various therapy areas including the COVID-19 pipeline, Influenza pipeline, RSV pipeline, combination pipeline, Lyme disease pipeline, Herpes pipeline, and Zika pipeline among others.
ARCT-2301: Meiji Seika is one of the largest Japanese pharma companies in infectious diseases. Therefore, the partnership between Arcturus and Meiji will help increase vaccine marketing. Arcturus Therapeutics already has another COVID-19 vaccine, ARCT-154, approved for use in the Japanese market.
Key Pipeline Products for mRNA Vaccines in the Infectious Diseases Market
Buy the Full Report for Additional Insights on the Key Pipeline Products for mRNA Vaccines in the Infectious Diseases Market, Download a Free Sample Report
mRNA Vaccines in Infectious Diseases Market – Competitive Landscape
The key companies in the mRNA vaccines in the infectious diseases market are Moderna, BioNTech, Pfizer, Arcturus Therapeutics, and AIM Vaccine Co Ltd among others. Moderna is the leading player within the pipeline landscape and is the only company investigating mRNA vaccines in a wide range of indications. Moderna’s mRNA-1345 vaccine for RSV and mRNA-1647 vaccine for CMV are projected to generate global revenues of $1.6 billion and $1.3 billion, respectively, by 2029.
Leading Companies in the mRNA Vaccines in Infectious Diseases Market
Buy the Full Report for More Company-Wise Insights into the mRNA Vaccines in Infectious Diseases Market, Download a Free Sample Report
Scope
- Overview of mRNA vaccinations and history of their therapeutics development.
- Current global industry trends together with their opportunities and challenges.
- Overview of currently marketed products within the global scope.
- Global pipeline analysis.
- Overview of leading companies within mRNA vaccines space.
- Brief market overview for major mRNA vaccines products.
Key Highlights
• Report deliverables in a form of PowerPoint report
• Global scope of marketed and pipeline products
Reasons to Buy
- Understand the trends shaping and driving the mRNA vaccines market.
- Identify the innovative technologies and key players leading the mRNA vaccines field.
- Recognize gaps and areas of unmet need within the mRNA vaccines market.
- Determine the current and outlook for mRNA vaccines according to key opinion leaders (KOLs).
BioNTech
Pfizer
Arcturus Therapeutics
AIM Vaccine Co Ltd
GSK
Sanofi
Novavax
CSPC Pharmaceutical
Gennova Biopharmaceutical
Walvax Biotechnology
Daiichi Sankyo
CSL
Suzhou Abogen
Table of Contents
Frequently asked questions
-
Which is the leading player in the mRNA vaccines in infectious diseases market?
Moderna is the leading player within the pipeline landscape and is the only company investigating mRNA vaccines in a wide range of indications.
-
Which are the main marketed products in the mRNA vaccines in infectious diseases market?
The key market products in the mRNA vaccines in the infectious diseases market are Comirnaty (BNT162b2/tozinameran), Spikevax (mRNA-1273), Nuvaxovid XBB.1.5, Gemcovac-19, AWcorna (Walvax), and Daichirona (DS-5670) among others.
-
Which are the main pipeline products in the mRNA vaccines in infectious diseases market?
The key pipeline products for mRNA vaccines in the infectious diseases market are ARCT-2301, DS-5670b, BNT-162b5, LVRNA-009, and mRNA-1283 among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Related reports
View more mRNA Vaccine reports


